Amundi’s Vertex Pharmaceuticals VRTX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $518M | Sell |
1,133,226
-1,965,643
| -63% | -$898M | 0.18% | 107 |
|
|
2025
Q1 | $1.5B | Sell |
3,098,869
-182,336
| -6% | -$88.3M | 0.55% | 29 |
|
|
2024
Q4 | $1.35B | Sell |
3,281,205
-478,031
| -13% | -$197M | 0.47% | 37 |
|
|
2024
Q3 | $1.73B | Buy |
3,759,236
+255,177
| +7% | +$117M | 0.64% | 26 |
|
|
2024
Q2 | $1.65B | Sell |
3,504,059
-79,024
| -2% | -$37.2M | 0.63% | 23 |
|
|
2024
Q1 | $1.41B | Buy |
3,583,083
+864,966
| +32% | +$341M | 0.61% | 27 |
|
|
2023
Q4 | $1.14B | Buy |
2,718,117
+774,696
| +40% | +$326M | 0.51% | 32 |
|
|
2023
Q3 | $721M | Buy |
1,943,421
+297,580
| +18% | +$110M | 0.35% | 57 |
|
|
2023
Q2 | $572M | Sell |
1,645,841
-393,077
| -19% | -$137M | 0.29% | 79 |
|
|
2023
Q1 | $656M | Sell |
2,038,918
-91,279
| -4% | -$29.4M | 0.35% | 59 |
|
|
2022
Q4 | $623M | Buy |
2,130,197
+304,875
| +17% | +$89.1M | 0.34% | 68 |
|
|
2022
Q3 | $551M | Buy |
1,825,322
+893,935
| +96% | +$270M | 0.33% | 65 |
|
|
2022
Q2 | $267M | Buy |
931,387
+338,889
| +57% | +$97M | 0.21% | 122 |
|
|
2022
Q1 | $163M | Sell |
592,498
-231,256
| -28% | -$63.8M | 0.11% | 214 |
|
|
2021
Q4 | $187M | Buy |
823,754
+133,856
| +19% | +$30.3M | 0.12% | 201 |
|
|
2021
Q3 | $125M | Buy |
689,898
+16,172
| +2% | +$2.93M | 0.09% | 247 |
|
|
2021
Q2 | $136M | Buy |
+673,726
| New | +$136M | 0.09% | 219 |
|